...
首页> 外文期刊>Cellular Physiology and Biochemistry >Activation of volume regulated chloride channels protects myocardium from ischemia/reperfusion damage in second-window ischemic preconditioning
【24h】

Activation of volume regulated chloride channels protects myocardium from ischemia/reperfusion damage in second-window ischemic preconditioning

机译:激活氯调节通道的通道可保护心肌免受第二窗缺血预处理中的缺血/再灌注损伤

获取原文
获取原文并翻译 | 示例
           

摘要

Activation of volume regulated chloride channels (VRCCs) has been shown to be cardioprotective in ischemic preconditioning (IPC) of isolated hearts but the underlying molecular mechanisms remain unclear. Recent independent studies support that ClC-3, a ClC voltage-gated chloride channel, may function as a key component of the VRCCs. Thus, ClC-3 knockout (Clcn3 ~(-/-)) mice and their age-matched heterozygous (Clcn3 ~(+/-)) and wild-type (Clcn3 ~(+/+)) littermates were used to test whether activation of VRCCs contributes to cardioprotection in early and/or second-window IPC. Targeted disruption of ClC-3 gene caused a decrease in the body weight but no changes in heart/body weight ratio. Telemetry ECG and echocardiography revealed no differences in ECG and cardiac function under resting conditions among all groups. Under treadmill stress (10 m/min for 10 min), the Clcn3 ~(-/-) mice had significant slower heart rate (648±12 bpm) than Clcn3 ~(+/+) littermates (737±19 bpm, n=6, P<0.05). Ex vivo IPC in the isolated working-heart preparations protected cardiac function during reperfusion and significantly decreased apoptosis and infarct size in all groups. In vivo early IPC significantly reduced infarct size in all groups including Clcn3 ~(-/-) mice (22.7±3.7% vs control 40.1±4.3%, n=22, P=0.004). Second-window IPC significantly reduced apoptosis and infarction in Clcn3 ~(+/+) (22.9±3.2% vs 45.7±5.4%, n=22, P<0.001) and Clcn3 ~(+/-) mice (27.5±4.1% vs 42.2±5.7%, n=15, P<0.05) but not in Clcn3 ~(-/-) littermates (39.8±4.9% vs 41.5±8.2%, n=13, P>0.05). Impaired cell volume regulation of the Clcn3 ~(-/-) myocytes may contribute to the failure of cardioprotection by second-window IPC. These results strongly support that activation of VRCCs may play an important cardioprotective role in second-window IPC.
机译:在离体心脏的缺血预处理(IPC)中,已激活了体积调节氯离子通道(VRCC)的心脏保护作用,但其潜在分子机制仍不清楚。最近的独立研究支持ClC-3(ClC电压门控氯化物通道)可能充当VRCC的关键组成部分。因此,使用ClC-3基因敲除(Clcn3〜(-/-))小鼠及其年龄匹配的杂合子(Clcn3〜(+/-))和野生型(Clcn3〜(+ / +))同窝仔来测试是否VRCC的激活有助于早期和/或第二窗口IPC的心脏保护。 ClC-3基因的靶向破坏导致体重下降,但心脏/体重比没有变化。遥测心电图和超声心动图显示,所有组在静息状态下的心电图和心功能均无差异。在跑步机压力下(10 m / min持续10分钟),Clcn3〜(-/-)小鼠的心率(648±12 bpm)比Clcn3〜(+ / +)同窝仔(737±19 bpm,n = 6,P <0.05)。离体工作心脏制剂中的离体IPC在再灌注过程中保护了心脏功能,并显着降低了所有组的细胞凋亡和梗塞面积。体内早期IPC在包括Clcn3〜(-/-)小鼠在内的所有组中均显着降低了梗塞面积(22.7±3.7%,而对照组为40.1±4.3%,n = 22,P = 0.004)。第二窗口IPC显着降低了Clcn3〜(+ / +)(22.9±3.2%vs 45.7±5.4%,n = 22,P <0.001)和Clcn3〜(+/-)小鼠(27.5±4.1%)的凋亡和梗死vs 42.2±5.7%,n = 15,P <0.05),而在Clcn3〜(-/-)同窝仔中则不然(39.8±4.9%vs 41.5±8.2%,n = 13,P> 0.05)。 Clcn3〜(-/-)心肌细胞的细胞体积调节受损可能是第二窗IPC导致心脏保护功能失败的原因。这些结果强烈支持VRCC的激活可能在第二窗口IPC中发挥重要的心脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号